NERV vs ACRS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

NERV

38.5
AI Score
VS
ACRS Wins

ACRS

46.2
AI Score

Investment Advisor Scores

NERV

39score
Recommendation
SELL

ACRS

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV ACRS Winner
Net Income -8.80M -41.33M NERV
Operating Income -7.51M -46.43M NERV
ROE -19.4% -33.2% NERV
ROA -7.9% -23.0% NERV
Total Assets 111.83M 179.69M ACRS
Cash 80.14M 19.17M NERV
Current Ratio 24.32 3.46 NERV

Relative Price Performance (Last 90 Days)

NERV 1M: +5.9% · 3M: -10.2% ACRS 1M: -8.9% · 3M: +21.7%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.2%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $4.15

ACRS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.1 · Price: $5.32

Fundamentals Snapshot

Metric NERV ACRS
Market Cap
Forward P/E -9.9 -6.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.1%
Gross Margin -7.6%
Operating Margin 0.0% -14.7%
EPS -36.29 -0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ACRS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.